• Immunotherapy Use Can Double Survival Rate of Melanoma Patients with Brain Metastasis, Large Study Reports
  • Survival Benefits of Checkpoint Inhibitors 2-times Higher in Men with Advanced Cancers Than Women, Study Finds
  • ‘Backpacks’ for T-cells Boost Immune Responses Against Tumors, Mouse Study Shows
  • BL-8040, Plus Chemo, Extends Survival in Relapsed/Refractory Leukemia Patients, Phase 2 Trial Shows
  • FDA Grants Priority Review to Keytruda-Chemo Combo for Metastatic NSCLC
  • Study Will Test CAR T-cell Immunotherapy in Young People with Brain, Spinal Cord Tumors
  • NBTXR3 for Soft Tissue Sarcoma May ‘Change Standard of Care,’ Researcher Says
  • FDA Approves Phase 2 Trial Testing AIVITA’s Vaccine for Aggressive Brain Cancer
  • Combination of Immune Cells Improves Chances of Successful Immunotherapy
  • DNA Vaccine To Be Tested in Advanced Colorectal Cancer Patients for 1st Time in Phase 1/2 Trial
  • Gene Editing of Healthy Cells Improves CAR T-cell Therapy for AML, Preclinical Study Shows
  • First Cancer Patient Dosed in Trial Investigating Immunotherapy ADXS-NEO